Toggle navigation
About Us
Science & Innovation
Products and Resources
Our Responsibility
Careers
Investors
Media
Toggle navigation
Press Releases
Featured News
Press Statements
Subscribe
Media Contacts
Press Releases
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Month Year
Su
Mo
Tu
We
Th
Fr
Sa
25
26
27
28
29
30
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
5
Cancel
Go
Year
All Years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
Category
All Categories
Corporate News
Product News
Vaccines News
Uncategorized
Keywords
Go
Advanced Search
Search
Search Headlines Only
Category
All Categories
Corporate News
Product News
Vaccines News
Uncategorized
From
To
Asset Types
Video
Audio
Photos
Documents
Events
Standard
Mar 12, 2006
New study furthers understanding of the role of dual antiplatelet therapy in the prevention of atherothrombotic events, including heart attack, stroke or cardiovascular death in broad population
Certain subgroups may benefit from dual therapy, for others it should be avoided
Feb 28, 2006
APIDRA® - a new rapid-acting insulin analog - is now available in the United States for hyperglycemia in adults with type 2 and type 1 diabetes
New prandial insulin with the OptiClik(R) delivery system can work with longer-acting insulins, such as basal insulin Lantus(R), providing a complementary approach to glucose control
Feb 24, 2006
Sanofi-aventis reports strong growth of 25.7% in 2005 adjusted EPS - Nearly 90% of synergies delivered by end 2005 - Dividend increased by 26.7%
Sanofi-aventis Reports Strong Growth of 25.7% in 2005 Adjusted EPS(1); Nearly 90% of synergies delivered by end 2005; Dividend increased by 26.7%
Feb 17, 2006
Sanofi-aventis received from the FDA an approvable letter for rimonabant for weight management and a non approvable letter for smoking cessation
Feb 14, 2006
The Journal of the American Medical Association publishes the RIO-North America study
Study Shows Rimonabant Maintains Improvements in Multiple Cardiometabolic Risk Factors for Up to Two Years
Feb 6, 2006
Sanofi Pasteur Delivers More H5N1 Vaccine for U.S. Government Pandemic Initiatives
New investigational doses include formulation with an adjuvant; Additional stockpile vaccine prepared
Feb 1, 2006
Sanofi Pasteur Experiences Unprecedented U.S. Demand for Influenza Vaccine for 2006-2007 Influenza Season
Jan 30, 2006
Dynamic growth in 2005 full-year consolidated net sales: up 9.3% on a comparable basis
Jan 18, 2006
FDA grants priority review to PLAVIX® (clopidogrel bisulfate) Supplemental New Drug Application (sNDA) for additional type of heart attack
Filing for STEMI Indication Also Submitted in Europe
Jan 13, 2006
Pfizer to purchase Sanofi-aventis rights to EXUBERA® in application of change of control clauses
Show
5
10
25
50
100
per page
«
1
…
84
85
86
87
88
89
90
…
95
»
Print
Email page
RSS